|4Jan 10, 4:18 PM ET

Allison David D. 4

4 · CinCor Pharma, Inc. · Filed Jan 10, 2023

Insider Transaction Report

Form 4
Period: 2023-01-06
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-06$8.34/sh+1,499$12,5021,499 total
    Exercise: $11.78From: 2023-01-06Exp: 2033-01-05Common Stock (1,499 underlying)
Footnotes (1)
  • [F1]This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION